Sharif Vakili has a breadth of experience at the intersection of healthcare, entrepreneurship, and academic research.
Prior to joining as an Associate, Sharif had worked in Business Development for RNA therapeutics company Translate Bio and in healthcare investing for SR One, where he supported cell therapy portfolio companies NKarta and Arcellx in Corporate Strategy roles.
Sharif is also the cofounder and CFO of USMLE Pro, a medical education company, as well as a resident physician in Internal Medicine at Stanford University. Academically, Sharif has published prolifically in clinical research and healthcare delivery. Sharif holds an MD from the Johns Hopkins School of Medicine, an MBA from Harvard Business School, and an MS and BS in Biology from Yale University.